The study, published June 10, 2020 in PLoS Biology, is the first to uncover the role a molecule called IRE1α plays in determining whether macrophages promote inflammation in the tissues surrounding cancer cells — a region known as the tumor microenvironment — and throw off the ability of other immune cells to fight cancer. Inflammation is known to promote tumor growth, making IRE1α an attractive target for future study and drug development.
